Persistent URL of this record https://hdl.handle.net/1887/108555
In Collections
This item can be found in the following collections:
![RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
- All authors
- Steg, P.G.; Mehta, S.R.; Jukema, J.W.; Lip, G.Y.H.; Gibson, C.M.; Kovar, F.; Kala, P.; Garcia-Hernandez, A.; Renfurm, R.W.; Granger, C.B.; RUBY-1 Investigators
- Date
- 2011-10-31
- Journal
- European Heart Journal
- Volume
- 32
- Issue
- 20
- Pages
- 2541 - 2554